ZYXEL-COMMUNICATIONS
13.1.2021 07:02:39 CET | Business Wire | Press release
Telenor Norway has selected Zyxel Communications’ 5G NR Fixed Wireless Access outdoor router – NR 7101 to roll out the world’s fastest and biggest 5G FWA.
As the first mobile operator of 5G in Scandinavia, Telenor is modernizing its existing network infrastructure with plans to offer nationwide 5G access by 2024. The company introduced wireless broadband in May 2019. Later that year, Telenor Norway partnered with Ericsson to modernize and deliver its nationwide 5G radio access network.
The selection of Zyxel Communications marks yet another important milestone for Telenor’s work in upgrading customers to 5G.
Zyxel’s 5G NR FWA outdoor router – NR 7101 uses modern antenna technology for Telenor to offer high-speed wireless connectivity. The company cited Zyxel’s innovative technology, effective local presence and collaborative approach as key reasons for its decision.
“Telenor is dedicated to providing Individual customers and businesses with faster speeds and more bandwidth,” said Camilla Amundsen, CMO, Fixed and TV of Telenor Norway. “Customers connect more innovative technologies and smart devices to their respective networks and expect maximum coverage everywhere. FWA supports the increasing number of individuals and families working and learning from home; where platforms such as video conferences, interactive learning, cloud-based enterprise solutions, TV streaming and online gaming demand significant broadband access. FWA is therefore an important part of Telenor’s network modernization and our partnership with Zyxel makes this possible.”
“Zyxel is helping Telenor reach an additional level of service for customers throughout Norway and oversee the world’s fastest, largest rollout of 5G FWA,” Amundsen added.
With Zyxel’s NR7101 outdoor router, Telenor also will provide customers with a smooth transition to 5G, while offering them access to its 4G network. This allows the provider to maximize speeds, regardless of network, and leverage its existing infrastructure investments throughout the rollout of 5G.
“Telenor is an industry pioneer in 5G and is at the forefront of deploying modern, next-generation networks for customers,” said Karsten Gewecke, SVP, Head of EMEA Regional BU at Zyxel Communications. “With our state-of-the-art 5G NR FWA technology, we’re playing a major role in delivering superior wireless access to customers everywhere throughout Norway.”
“Combined with short delivery time, high speeds and increased reliability, FWA is an attractive solution for many customers – not only existing DSL customers,” Karsten Gewecke concludes.
Telenor currently offers 5G in the following areas: Trondheim, Bergen, Kongsberg, Elverum, Bodø, Askvoll, Telenor Fornebu, Kvitfjell, Longyearbyen, Herøya, Frøya and Spikersuppa in Oslo. The service provider also is actively deploying 5G in Ålesund, Kristiansand, Fredrikstad, Tromsø and Bodø. In addition, Telenor plans to make 5G available nationwide in Norway by 2024. Likewise, after December 2020, all new FWA-customers are offered Zyxel’s 5G-ready FWA outdoor router, which ensures a smooth transition for subscribers not yet covered by 5G.
About Telenor Norway
Telenor Norway AS is the country's largest provider of telecommunications and digital services. Its infrastructure is the foundation of the digitization of Norway with world-class coverage and speeds. Its services and products contribute to increased productivity and provide access to all digital content. Its safety and emergency response organization works 24/7 to keep customers safe, and Telenor Norway takes special social responsibility to create safety for children and young people online.
About Zyxel Communications
Zyxel Communications delivers technological innovations and has connected the world to the Internet for more than 30 years. Whether it’s a matter of establishing access through fixed or mobile broadband solutions, Zyxel Communications offers a comprehensive and flexible portfolio of products that’s keeping service providers ahead of the competition.
Read the full Telenor customer story here .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210112006083/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom